Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis
Condition(s):Adenocarcinoma of LungLast Updated:January 5, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Adenocarcinoma of LungLast Updated:January 5, 2021Unknown status
Condition(s):Adenocarcinoma of LungLast Updated:June 21, 2016Unknown status
Condition(s):Adenocarcinoma of LungLast Updated:October 15, 2021Not yet recruiting
Condition(s):Adenocarcinoma of LungLast Updated:February 5, 2016Active, not recruiting
Condition(s):Adenocarcinoma of LungLast Updated:August 7, 2023Recruiting
Condition(s):Adenocarcinoma of LungLast Updated:July 21, 2023Completed
Condition(s):Adenocarcinoma of LungLast Updated:December 11, 2019Terminated
Condition(s):Adenocarcinoma of Lung (Disorder)Last Updated:March 27, 2017Unknown status
Condition(s):Adenocarcinoma of Lung Stage IV; Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, SomaticLast Updated:July 30, 2020Completed
Condition(s):Lung AdenocarcinomaLast Updated:July 26, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.